Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3109/07357907.2015.1047506 http://scihub22266oqcxt.onion/10.3109/07357907.2015.1047506 C4666677!4666677!26068056     free     free     free Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Cancer+Invest 2015 ; 33 (8): 331-9 Nephropedia Template TP {{tp|p=26068056|t=2015. Quality and Outcomes of Treatment of Hypercalcemia of Malignancy |pdf=|usr=}}{{26068056}} gab.com Text Quality and Outcomes of Treatment of Hypercalcemia of Malignancy JO: Cancer Invest http://www.kidney.de/pget.php?&tw=1&pmid=26068056 #FOAvip Using a nationwisde database, 4874 patients with hypercalcemia of malignancy were identified. The in-hospital mortality rate was 6.8%. Overall, 1971 (40.4%) patients received pamidronate and 1399 (28.7%) received zoledronic acid during hospitalization. Calcitonin was utilized in 1337 (27.4%) patients while glucocorticoids were administered to 1311 (26.9%). Use of contraindicated medications was noted in 136 (2.8%) patients who received thiazide diuretics and 12 (0.2%) who received lithium. Tumor site, presence of bone metastases, and severity of illness were predictors of treatment. There was no association between treatment with bisphosphonates, calcitonin, or glucocorticoids and morbidity or mortality. Twit Text FOAVip Quality and Outcomes of Treatment of Hypercalcemia of Malignancy ????Cancer Invest http://www.kidney.de/pget.php?&tw=1&pmid=26068056 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26068056 #FOAvip English Wikipedia <ref>{{Cite pmid|26068056}}</ref> Quality and Outcomes of Treatment of Hypercalcemia of Malignancy #MMPMID26068056 Wright JD; Tergas AI; Ananth CV; Burke WM; Hou JY; Chen L; Neugut AI; Richards CA; Hershman DL Cancer Invest 2015[Sep]; 33 (8): 331-9 PMID26068056show ga Using a nationwisde database, 4874 patients with hypercalcemia of malignancy were identified. The in-hospital mortality rate was 6.8%. Overall, 1971 (40.4%) patients received pamidronate and 1399 (28.7%) received zoledronic acid during hospitalization. Calcitonin was utilized in 1337 (27.4%) patients while glucocorticoids were administered to 1311 (26.9%). Use of contraindicated medications was noted in 136 (2.8%) patients who received thiazide diuretics and 12 (0.2%) who received lithium. Tumor site, presence of bone metastases, and severity of illness were predictors of treatment. There was no association between treatment with bisphosphonates, calcitonin, or glucocorticoids and morbidity or mortality. äQuality and Outcomes of Treatment of Hypercalcemia of Malignancy (epmc).pdf DeepDyve Pubget Overpricing